Quick Answer
Evofem Biosciences, Inc. reported Long-Term Debt of $7.21 million for fiscal year 2015.
Evofem Biosciences, Inc. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2015 | $7.21M | -26.0% |
| 2014 | $9.74M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| June 30, 2016 | $2.81M | -67.4% | -10.9% |
| March 31, 2016 | $3.15M | -66.1% | -56.2% |
| December 31, 2015 | $7.21M | -26.0% | -9.0% |
| September 30, 2015 | $7.92M | — | -8.1% |
| June 30, 2015 | $8.62M | — | -7.3% |
| March 31, 2015 | $9.30M | — | -4.5% |
| December 31, 2014 | $9.74M | — | — |
- Evofem Biosciences, Inc. showed a decrease of -26.0% in Long-Term Debt compared to the prior fiscal year.
- Over the 2014–2015 period, Evofem Biosciences, Inc.’s long-term debt has declined by 26.0% (from $9.74 million to $7.21 million).
- The most recent figure is from Evofem Biosciences, Inc.’s fiscal year 2016 report (Form 10-K), filed with the SEC on March 23, 2017.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: